MetaCap

Biote (BTMD) vs IM Cannabis (IMCC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Biote is the larger company by market cap ($37.6 million vs $3.1 million), about 12.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

BTMD versus IMCC key metrics
MetricBTMDIMCC
Share price$1.11$1.90
Market cap$37.63M$3.13M
1-day change-2.63%-2.06%
YTD return-57.31%—
1-year return-60.92%—
5-year return-88.64%—
P/E ratio (TTM)7.93—
Forward P/E2.47—
EPS (TTM)$0.14$-71.41
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$3.26$77.10
52-week low$1.09$1.55
Distance from 52-week high-65.95%-97.54%
Average volume230.27K2.75M
Shares outstanding28.68M1.65M
SectorHealth CareHealth Care
Industry Medicinal Chemicals and Botanical Products Medicinal Chemicals and Botanical Products

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Biote is about 12.0 times larger than IM Cannabis by market value ($37.63M vs $3.13M).

BTMD vs IMCC FAQ

Which is bigger, Biote or IM Cannabis?

Biote (BTMD) is larger, with a market capitalization of $37.63M compared with $3.13M for IM Cannabis (IMCC).

Are Biote and IM Cannabis in the same industry?

Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.

More comparisons